Clinical Trial Update: Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD) [NA]

View source ↗

Summary

A terminated clinical trial assessing the effect of Harvoni on proteinuria and eGFR in patients with hepatitis C–associated chronic kidney disease, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hepatitis C

Drugs mentioned

• HARVONI (Ledipasvir and Sofosbuvir)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatitis C, Chronic Kidney Disease | NA | Status: TERMINATED | Results posted: 2020-01-09